INSULINTHEMOMENT
LIVE

Serial Number

99636796

Owner

MannKind Corporation

Attorney

Jaclyne D. Wallace

Filing Date

Feb 5, 2026

Add to watchlist:

No watchlists yet
View on USPTO

INSULINTHEMOMENT Trademark

Serial Number: 99636796

INSULINTHEMOMENT is a trademark filed by MannKind Corporation on February 5, 2026. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

MannKind Corporation (7 trademarks)

1 Casper Street
Danbury, CT 06810

Entity Type: 03

Trademark Details

Filing Date

February 5, 2026

Registration Date

Not Registered

Goods & Services

Arranging and conducting conferences, seminars and non-downloadable webinars in the field of health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; providing podcasts in the field of health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals

Medical information services, including providing a website in the medical, pharmaceutical and health fields featuring information related to health, wellness, healthcare, patient support services, pharmaceuticals, pharmaceutical access, drug safety and/or drug compatibility in relation to therapy and treatment of individuals, adherence to pharmaceutical protocols, and the diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical care consulting services in the fields of diagnostics, patient treatment and treatment protocols

Pharmaceutical preparations for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of lung diseases and disorders, including, pulmonary arterial hypertension and interstitial lung diseases, including, idiopathic pulmonary fibrosis, and lung infections, including, mycobacterial infections

Medical devices, namely, devices for the administration of pharmaceuticals for inhalation for the treatment of lung diseases and disorders, including pulmonary arterial hypertension and interstitial lung diseases, including, idiopathic pulmonary fibrosis, and lung infections, including, mycobacterial infections; Medical devices, namely, devices for the administration of pharmaceuticals for the treatment of diabetes, endocrine diseases and disorders, metabolic diseases and disorders

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 3, 2026 GNRN
NON-FINAL ACTION E-MAILED
Jun 3, 2026 GNRT
NON-FINAL ACTION WRITTEN
Jun 3, 2026 CNRT
ASSIGNED TO EXAMINER
Jun 3, 2026 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 2, 2026 NWOS
APPLICATION FILING RECEIPT MAILED
Feb 5, 2026 MAFR
NEW APPLICATION ENTERED
Feb 5, 2026 NWAP